Investigating the mode of action of ACB1801 on increasing TAP1 and improving cancer immunotherapy

Project Details

AcronymINCEPTOR
StatusActive
Effective start/end date1/04/24 → 31/03/26

Funding

  • European Commission: €191,760.00